Microbial biofilm matrix and wound surface debris

The microbial biofilm matrix and wound surface debris represent a complex, non-cellular target environment critical in chronic wound management and persistent infections. The biofilm matrix is primarily composed of extracellular polymeric substances (EPS), including polysaccharides, proteins, and extracellular DNA, which provide a protective shield for pathogenic microorganisms against the host immune system and antimicrobial agents (National Institutes of Health, 2021). Wound surface debris, including necrotic tissue, slough, and fibrin, serves as a physical barrier and a reservoir for bacterial growth, further impeding the healing process (PubMed, 2020). Therapeutic strategies targeting this environment involve enzymatic debridement to break down necrotic proteins and anti-biofilm agents designed to degrade the EPS matrix (StatPearls, 2023). By disrupting these structural components, treatments aim to expose underlying pathogens to antibiotics and promote the formation of healthy granulation tissue. This target is central to treating conditions like diabetic foot ulcers, pressure sores, and chronic surgical site infections (Journal of Wound Care, 2022).

Other names

Extracellular polymeric substances (EPS)Biofilm EPSNecrotic tissueWound sloughEscharFibrinous debrisWound bed debris

Proteolytic degradation of necrotic proteins and enzymatic hydrolysis of biofilm-associated polysaccharides and extracellular DNA to disrupt structural integrity and facilitate debridement.